The Recombinant Human EMMPRIN/CD147 Fc Chimera (NS0) Protein from R&D Systems is derived from NS0. The Recombinant Human EMMPRIN/CD147 Fc Chimera (NS0) Protein has been validated for the following applications: Bioactivity.
EMMPRIN/CD147 Fc嵌合体蛋白冻干来自a 0.2 m选择溶液在PBS
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain
Observed Molecular Weight :
60-65 kDa, reducing conditions
Theoretical Molecular Weight :
47.4 kDa (monomer)
Details of Functionality :
Measured by the ability of the immobilized protein to induce active MMP-1 secretion by NHLF human normal lung fibroblasts. The ED50 for this effect is 2-8á╡g/mL.
<0.10 EU per 1 ╡g of the protein by the LAL method.
NS0-derived Recombinant Human EMMPRIN/CD147 Fc Chimera (NS0) Protein, CF
5F7, basigin, basigin (Ok blood group), BSG, CD147, CD147 antigen, Collagenase stimulatory factor, EMMPRINTCSF, Extracellular matrix metalloproteinase inducer, Leukocyte activation antigen M6, M6, OK, OK blood group antigen, Tumor cell-derived collagenase stimulatory factor
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 ░C as supplied. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, -20 to -70 ░C under sterile conditions after reconstitution.
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.